O-2113
O-2113 is a synthetic cannabinoid that has been studied for its potential therapeutic effects. It is a member of the cannabinoid class of compounds, which interact with the endocannabinoid system in the body.
Chemical Structure and Properties[edit | edit source]
O-2113 is chemically related to other cannabinoids, such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The specific chemical structure of O-2113 includes a core cannabinoid structure with various functional groups that influence its interaction with cannabinoid receptors.
Pharmacology[edit | edit source]
O-2113 primarily interacts with the CB1 and CB2 receptors in the endocannabinoid system. These receptors are part of the G protein-coupled receptor family and are involved in various physiological processes, including pain sensation, mood regulation, and immune response.
CB1 Receptor[edit | edit source]
The CB1 receptor is predominantly found in the central nervous system, including the brain and spinal cord. Activation of CB1 receptors by cannabinoids like O-2113 can result in psychoactive effects, although the specific effects of O-2113 are still under investigation.
CB2 Receptor[edit | edit source]
The CB2 receptor is primarily located in the immune system and peripheral tissues. Activation of CB2 receptors is associated with anti-inflammatory and immunomodulatory effects. O-2113's interaction with CB2 receptors suggests potential therapeutic applications in conditions involving inflammation and immune response.
Therapeutic Potential[edit | edit source]
Research on O-2113 has explored its potential in various medical conditions. Some studies suggest that it may have analgesic (pain-relieving) properties, making it a candidate for the treatment of chronic pain conditions. Additionally, its interaction with the CB2 receptor indicates potential benefits in inflammatory diseases and immune disorders.
Safety and Side Effects[edit | edit source]
As with other synthetic cannabinoids, the safety profile of O-2113 is an important consideration. Potential side effects may include dizziness, dry mouth, and changes in appetite. Long-term safety data is limited, and further research is needed to fully understand the risks associated with its use.
Legal Status[edit | edit source]
The legal status of O-2113 varies by jurisdiction. In some regions, synthetic cannabinoids are regulated under controlled substances laws, while in others, they may be available for research purposes only.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD